Deutsche Bank
IPSC icon

Deutsche Bank’s Century Therapeutics IPSC Stock Holding History

Deutsche Bank’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-96,140
Closed -$46.1K – 3664
2025
Q1 		$46.1K Sell
96,140
-97,228
-50% -$73K ﹤0.01% 3389
2024
Q4 		$195K Buy
193,368
+173,849
+891% +$237K ﹤0.01% 3102
2024
Q3 		$33.4K Buy
19,519
+12,258
+169% +$24K ﹤0.01% 3419
2024
Q2 		$18.5K Sell
7,261
-2,473
-25% -$7.82K ﹤0.01% 3433
2024
Q1 		$40.7K Sell
9,734
-18,757
-66% -$79.4K ﹤0.01% 3438
2023
Q4 		$94.6K Buy
28,491
+27,382
+2,469% +$49.9K ﹤0.01% 3243
2023
Q3 		$2.22K Sell
1,109
-22,470
-95% -$59.8K ﹤0.01% 3638
2023
Q2 		$74.5K Buy
23,579
+11,119
+89% +$35.8K ﹤0.01% 3380
2023
Q1 		$43.2K Buy
12,460
+5,114
+70% +$22.5K ﹤0.01% 3582
2022
Q4 		$37.7K Buy
7,346
+136
+2% +$1.28K ﹤0.01% 3643
2022
Q3 		$71K Sell
7,210
-1,345
-16% -$14.2K ﹤0.01% 3476
2022
Q2 		$72K Sell
8,555
-1,798
-17% -$17.6K ﹤0.01% 3651
2022
Q1 		$131K Buy
10,353
+3,178
+44% +$42.1K ﹤0.01% 3475
2021
Q4 		$114K Buy
7,175
+380
+6% +$7.14K ﹤0.01% 3648
2021
Q3 		$171K Buy
+6,795
New +$184K ﹤0.01% 3648

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank's IPSC Position: Q2 2025 in Review

Deutsche Bank sold out of Century Therapeutics (IPSC) in Q2 2025, closing a stake of 96,140 shares — an estimated $46.1K sold.

Deutsche Bank first reported a position in IPSC in Q3 2021 and held it in 15 quarters. The position peaked at $195K in Q4 2024. 65 funds tracked by Wall St. Rank hold IPSC as of Q2 2025.

  • Deutsche Bank reported no remaining Century Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Deutsche Bank sold 96,140 Century Therapeutics shares in Q2 2025, an estimated $46.1K.
  • Deutsche Bank first reported a position in Century Therapeutics in Q3 2021 and held it in 15 quarters.
  • Deutsche Bank's Century Therapeutics position peaked at $195K in Q4 2024.
  • 65 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2025.

Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.